The Efficacy of Rasburicase and Rituximab Combined with FAB Chemotherapy in Children and Adolescents with Newly Diagnosed Stage III/IV, BM plus and CNS plus Mature B-NHL: A Children's Oncology Group Report

被引：0
|
作者：
Goldman, Stanton [1 ]
Galardy, Paul J. [2 ]
Smith, Lynette [3 ]
Perkins, Sherrie L. [4 ,5 ]
Shiramizu, Bruce [6 ]
Gross, Thomas [7 ]
Sanger, Warren G. [8 ]
Harrison, Lauren [9 ]
Cairo, Mitchell S. [9 ]
机构：
[1] Med City Childrens, Dallas, TX USA
[2] Mayo Clin, Rochester, MN USA
[3] Univ Nebraska Med Ctr, COPH Biostat, Omaha, NE USA
[4] Univ Utah, Dept Pathol, Salt Lake City, UT USA
[5] ARUP Labs, Salt Lake City, UT USA
[6] Univ Hawaii, Honolulu, HI 96822 USA
[7] Ohio State Univ, Nationwide Childrens Hosp, Columbus, OH 43210 USA
[8] Univ Nebraska, Med Ctr, Human Genet Lab, Omaha, NE USA
[9] New York Med Coll, Valhalla, NY 10595 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1161 / 1162
页数：2
相关论文
共 47 条
  • [21] EFFECTIVE AND SAFE ACUTE TUMOR LYSIS SYNDROME (ATLS) PROSPHYLAXIS WITH RASBURICASE AND NON-ALKALINE HYDRATION IN CHILDREN AND ADOLESCENTS WITH ADVANCED STAGE III/IV INTERMEDIATE RISK B-CELL NON-HODGKIN LYMPHOMA (B-NHL): A CHILDREN'S ONCOLOGY GROUP REPORT
    Goldman, Stanton
    Lynch, James
    Harrison, Lauren
    Cairo, Mitchell S.
    PEDIATRIC BLOOD & CANCER, 2009, 52 (06) : 713 - 714
  • [22] Improved outcomes in CNS-positive pediatric Burkitt lymphoma/leukemia using rituximab plus FAB group C1 chemotherapy without CNS radiation: a Children's Oncology Group report
    Frazer, J. K.
    Goldman, S. C.
    Smith, L.
    Harrison, L.
    Perkins, S. L.
    Cairo, M. S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 : 3 - 3
  • [23] INTER-B NHL-RITUX-2010 TRIAL FOR CHILDREN/ADOLESCENTS WITH HIGH-RISK MATURE B-NHL: SAFETY AND EFFICACY IN PATIENTS TREATED WITH RITUXIMAB AND LMB CHEMOTHERAPY
    Minard-Colin, V.
    Auperin, A.
    Burke, A.
    Alexander, S.
    Moreno, M.
    Buffardi, S.
    Uyttebroeck, A.
    Bollard, C.
    Zsiros, J.
    Csoka, M.
    Kazanowska, B.
    Chiang, A.
    Verschuur, A.
    Miles, R.
    Wotherspoon, A.
    Barkauskas, D.
    Wheatley, K.
    Vassal, G.
    Adamson, P.
    Gross, T.
    Patte, C.
    Pillon, M.
    LEUKEMIA RESEARCH, 2022, 121 : S43 - S43
  • [24] SURVIVAL IN CHILDREN AND ADOLESCENTS (C plus A) WITH MATURE B-NHL PROGRESSING OR RELAPSING FROM TREATMENT ON FAB/LMB 96: TUMOR BURDEN AND TIME TO RELAPSE ARE POOR PROGNOSTIC FACTORS
    Cairo, Mitchell S.
    Sposto, Richard
    Fan, Jin
    Gerrard, Mary
    Auperin, Anne
    Pinkerton, Ross
    McCarthy, Keith
    Raphael, Martine
    Harrison, Lauren
    Goldman, Stanton
    Patte, Catherine
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 855 - 855
  • [25] MINIMAL DISSEMINATED DISEASE/RESIDUAL DISEASE IN CHILDREN AND ADOLESCENTS WITH MATURE B-CELL NON-HODGKIN LYMPHOMA (B-NHL) MAY IMPACT THE RISK OF RELAPSE: A CHILDREN'S ONCOLOGY GROUP REPORT
    Shiramizu, B.
    Goldman, S.
    Smith, L.
    Harrison, L.
    Van De Ven, C.
    Gross, T. G.
    Sanger, W.
    Perkins, S.
    Cairo, M. S.
    ANNALS OF ONCOLOGY, 2011, 22 : 114 - 114
  • [26] Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report
    Barth, Matthew J.
    Goldman, Stanton
    Smith, Lynette
    Perkins, Sherrie
    Shiramizu, Bruce
    Gross, Thomas G.
    Harrison, Lauren
    Sanger, Warren
    Geyer, Mark B.
    Giulino-Roth, Lisa
    Cairo, Mitchell S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (05) : 678 - 683
  • [27] Therapy of Advanced-stage Mature B-cell Lymphoma and Leukemia in Children and Adolescents With Rituximab and Reduced Intensity Induction Chemotherapy (B-NHL 2004M Protocol): The Results of a Multicenter Study
    Samochatova, Elena V.
    Maschan, Alexey A.
    Shelikhova, Larisa N.
    Myakova, Natalia V.
    Belogurova, Margarita B.
    Khlebnikova, Olga P.
    Shamardina, Anastasia V.
    Ryskal, Olga V.
    Roumiantseva, Julia V.
    Konovalov, Dmitriy M.
    Dubrovina, Maria E.
    Rumyantsev, Alexander G.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2014, 36 (05) : 395 - 401
  • [28] Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukemia: A Children's Oncology Group (COG) report.
    Barth, Matthew John
    Goldman, Stanton
    Smith, Lynette
    Perkins, Sherrie L.
    Shiramizu, Bruce
    Gross, Thomas G.
    Harrison, Lauren
    Sanger, Warren
    Geyer, Mark B.
    Giulino, Lisa B.
    Cairo, Mitchell S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children's oncology group report
    Shiramizu, Bruce
    Goldman, Stanton
    Kusao, Ian
    Agsalda, Melissa
    Lynch, James
    Smith, Lynette
    Harrison, Lauren
    Morris, Erin
    Gross, Thomas G.
    Sanger, Warren
    Perkins, Sherrie
    Cairo, Mitchell S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (06) : 758 - 763
  • [30] Use of immunoglobulin heavy chain primer pools to assess minimal residual disease/persistent disease (MRD/PD) in children and adolescents with mature B-cell non-Hodgkin lymphoma (B-NHL): A Children's Oncology Group report.
    Shiramizu, B.
    Goldman, S.
    Kusao, I.
    Agsalda, M.
    Lynch, J. C.
    Harrison, L.
    Gross, T. G.
    Sanger, W.
    Perkins, S. L.
    Cairo, M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345